Skip to main content
main-content

Zeitschrift

Cardiovascular Drugs and Therapy

Cardiovascular Drugs and Therapy 3/2017

Ausgabe 3/2017

Inhaltsverzeichnis ( 12 Artikel )

21.07.2017 | EDITORIAL | Ausgabe 3/2017

Mechanistic Insights of Empagliflozin-Mediated Cardiac Benefits: Nearing the Starting Line

Editorial to: “Empagliflozin Improves Left Ventricular Diastolic Dysfunction in a Genetic Model of Type 2 Diabetes” by N. Hammoudi et al.
Manisha Gupte, Prachi Umbarkar, Hind Lal

22.06.2017 | ORIGINAL ARTICLE | Ausgabe 3/2017

Empagliflozin Improves Left Ventricular Diastolic Dysfunction in a Genetic Model of Type 2 Diabetes

Nadjib Hammoudi, Dongtak Jeong, Rajvir Singh, Ahmed Farhat, Michel Komajda, Eric Mayoux, Roger Hajjar, Djamel Lebeche

27.05.2017 | SHORT COMMUNICATION | Ausgabe 3/2017

The Role of MKP-1 in Insulin-Induced Cardioprotection

Ingrid Webster, Angelique Smith, Amanda Lochner, Barbara Huisamen

10.07.2017 | ORIGINAL ARTICLE | Ausgabe 3/2017

Argatroban Attenuates Diabetic Cardiomyopathy in Rats by Reducing Fibrosis, Inflammation, Apoptosis, and Protease-Activated Receptor Expression

Yogesh Bulani, Shyam Sunder Sharma

28.07.2017 | ORIGINAL ARTICLE | Ausgabe 3/2017

Plasma Lipidome Analysis by Liquid Chromatography-High Resolution Mass Spectrometry and Ion Mobility of Hypertriglyceridemic Patients on Extended-Release Nicotinic Acid: a Pilot Study

Véronique Ferchaud-Roucher, Mikaël Croyal, Thomas Moyon, Yassine Zair, Michel Krempf, Khadija Ouguerram

27.06.2017 | ORIGINAL ARTICLE | Ausgabe 3/2017 Open Access

Identifying Subpopulations with Distinct Response to Treatment Using Plasma Biomarkers in Acute Heart Failure: Results from the PROTECT Trial

Differential Response in Acute Heart Failure
Licette C. Y. Liu, Mattia A. E. Valente, Douwe Postmus, Christopher M. O’Connor, Marco Metra, Howard C. Dittrich, Piotr Ponikowski, John R. Teerlink, Gad Cotter, Beth Davison, John G. F. Cleland, Michael M. Givertz, Daniel M. Bloomfield, Dirk J. van Veldhuisen, Hans L. Hillege, Peter van der Meer, Adriaan A. Voors

18.05.2017 | ORIGINAL ARTICLE | Ausgabe 3/2017

Effect of Apixaban on All-Cause Death in Patients with Atrial Fibrillation: a Meta-Analysis Based on Imputed Placebo Effect

Patrícia O. Guimarães, Renato D. Lopes, Daniel M. Wojdyla, Azmil H. Abdul-Rahim, Stuart J. Connolly, Greg C. Flaker, Junyuan Wang, Michael Hanna, Christopher B. Granger, Lars Wallentin, Kennedy R. Lees, John H. Alexander, John J.V. McMurray

14.07.2017 | ORIGINAL ARTICLE | Ausgabe 3/2017

Primary Care Physician Perspectives on Barriers to Statin Treatment

Rikki M. Tanner, Monika M. Safford, Keri L. Monda, Benjamin Taylor, Ronan O’Beirne, Melanie Morris, Lisandro D. Colantonio, Ricardo Dent, Paul Muntner, Robert S. Rosenson

24.05.2017 | REVIEW ARTICLE | Ausgabe 3/2017

The Role of SGLT-2 Inhibitors as Part of Optimal Medical Therapy in Improving Cardiovascular Outcomes in Patients with Diabetes and Coronary Artery Disease

Wassim Mosleh, Abhinav Sharma, Mandeep S. Sidhu, Brian Page, Umesh C. Sharma, Michael E. Farkouh

22.06.2017 | REVIEW ARTICLE | Ausgabe 3/2017

Triple Antithrombotic Therapy in Atrial Fibrillation Patients Undergoing PCI: a Fading Role

Dimitrios Alexopoulos, Panagiotis Vlachakis, John Lekakis

18.07.2017 | REVIEW ARTICLE | Ausgabe 3/2017 Open Access

Human iPSC-Derived Cardiomyocytes for Investigation of Disease Mechanisms and Therapeutic Strategies in Inherited Arrhythmia Syndromes: Strengths and Limitations

Simona Casini, Arie O. Verkerk, Carol Ann Remme

28.07.2017 | REVIEW ARTICLE | Ausgabe 3/2017 Open Access

MicroRNAs in Atrial Fibrillation: from Expression Signatures to Functional Implications

Nicoline W. E. van den Berg, Makiri Kawasaki, Wouter R. Berger, Jolien Neefs, Eva Meulendijks, Anke J. Tijsen, Joris R. de Groot

Aktuelle Ausgaben

Neu im Fachgebiet Kardiologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Kardiologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise